Form 8-K - Current report:
SEC Accession No. 0001564590-20-027121
Filing Date
2020-05-28
Accepted
2020-05-28 07:05:41
Documents
14
Period of Report
2020-05-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-8k_20200527.htm   iXBRL 8-K 40298
2 EX-99.1 mygn-ex991_32.htm EX-99.1 17151
3 GRAPHIC gcko1zu352zm000001.jpg GRAPHIC 4229
  Complete submission text file 0001564590-20-027121.txt   196446

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mygn-20200527.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20200527_lab.xml EX-101.LAB 18732
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20200527_pre.xml EX-101.PRE 11167
11 EXTRACTED XBRL INSTANCE DOCUMENT mygn-8k_20200527_htm.xml XML 3414
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 20916908
SIC: 2835 In Vitro & In Vivo Diagnostic Substances